PULSE the living trend engine
▲ Peaking Business

Allergy medication recalled over potentially ‘life-threatening’ cross-contamination

An urgent recall of Cetirizine Hydrochloride tablets is underway due to reports of potentially life-threatening ranitidine cross-contamination.

5sources
5articles
14velocity
+0%since first seen
3h agofirst detected

Velocity

How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →

The brief

A recall has been initiated for Cetirizine Hydrochloride tablets. The action follows reports identifying potential cross-contamination with ranitidine.

Coverage from iHeart, Facebook, WSB-TV, USA Today, and The Hill highlights the necessity for consumers to check their medication bottles. Reports emphasize the cross-contamination poses a potentially life-threatening risk to users.

Consumers are currently advised to check their medication products against the recall notice. Coverage does not yet specify the complete list of affected batches or the specific manufacturers involved in the recall.

Synthesized by PULSE from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 2h ago.

Quick answers

What medication is being recalled?

Cetirizine Hydrochloride tablets are subject to a recall.

What is the reason for the recall?

The recall is due to potential cross-contamination with ranitidine.

Are there specific brands mentioned?

Coverage identifies the medication as Cetirizine Hydrochloride but does not specify individual brands.

Coverage (5)

Topics

Related trends

↓ Cooling Business

The Great Peptide Cash Grab Has Begun

An FDA advisory panel review of seven specific peptides has triggered industry-wide attention and scrutiny regarding the future of the telehealth market.

6 sources 6 articles v 4 12m ago